Isosorbide mononitrate: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 27: Line 27:
'''| [[Isosorbide mononitrate adverse reactions|Adverse Reactions]]'''
'''| [[Isosorbide mononitrate adverse reactions|Adverse Reactions]]'''
'''| [[Isosorbide mononitrate drug interactions|Drug Interactions]]'''
'''| [[Isosorbide mononitrate drug interactions|Drug Interactions]]'''
'''| [[Isosorbide mononitrate use in specific populations|Use in Specific Populations]]'''
'''| [[Isosorbide mononitrate overdosage|Overdosage]]'''
'''| [[Isosorbide mononitrate overdosage|Overdosage]]'''
'''| [[Isosorbide mononitrate description|Description]]'''
'''| [[Isosorbide mononitrate description|Description]]'''

Revision as of 03:04, 31 January 2014

Isosorbide mononitrate
ISOSORBIDE MONONITRATE tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Description
Clinical Pharmacology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information, click here.

Overview

Isosorbide mononitrate is a drug used principally in the treatment of angina pectoris and acts by dilating the blood vessels so as to reduce the blood pressure. It is sold in the USA by Kremers Urban under the trade name Monoket, also sold in the USA under the name Imdur, and marketed in the UK under the trade names: Monosorb, Chemydur. In India, this drug is available under the brand names of Ismo, Isonorm, Monotrate, Solotrate, and Monit.

Category

Vasodilator

US Brand Names

ISOSORBIDE MONONITRATE tablet® [Zydus Pharmaceuticals (USA) Inc.]

FDA Package Insert

| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

Mechanism of Action

ISMN extended-release tablets are an oral extended-release formulation of ISMN, the major active metabolite of isosorbide dinitrate; most of the clinical activity of the dinitrate is attributable to the mononitrate.

The principal pharmacological action of ISMN and all organic nitrates in general is relaxation of vascular smooth muscle, producing dilatation of peripheral arteries and veins, especially the latter. Dilatation of the veins promotes peripheral pooling of blood, decreases venous return to the heart, thereby reducing left ventricular end-diastolic pressure and pulmonary capillary wedge pressure (preload). Arteriolar relaxation reduces systemic vascular resistance, and systolic arterial pressure and mean arterial pressure (afterload). Dilatation of the coronary arteries also occurs. The relative importance of preload reduction, afterload reduction, and coronary dilatation remains undefined.[1]

References

  1. "ISOSORBIDE MONONITRATE TABLET [ZYDUS PHARMACEUTICALS (USA) INC.]". Retrieved 30 January 2014.